Zobrazeno 1 - 10
of 347
pro vyhledávání: '"Taizo, Shiraishi"'
Autor:
Remi Semba, Katsunori Uchida, Yoshihumi Hirokawa, Taizo Shiraishi, Takehisa Onishi, Takeshi Sasaki, Takahiro Inoue, Masatoshi Watanabe
Publikováno v:
BMC Urology, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background Prostate cancer patients with pathological prognostic factors have a poor prognosis, but it is unclear whether pathological prognostic factors are associated with prognosis limited to low-risk patients with good prognosis accordin
Externí odkaz:
https://doaj.org/article/0d754f1f87574bdb85a4ed03df165066
Autor:
Hiroaki Ikeda, Hiroshi Shiku, Shigehisa Kitano, Koji Kato, Shinichi Kageyama, Yoshihiro Miyahara, Mikiya Ishihara, Kazuto Takesako, Takashi Watanabe, Akihiko Matsumine, Makoto Endo, Tomomi Yamada, Satoshi Okumura, Naomi Kiyota, Kimikazu Yakushijin, Kohichi Takada, Shinichiro Kobayashi, Yasuhiro Nagata, Taizo Shiraishi, Keizo Horibe, Hiroshi Miwa
Publikováno v:
BMJ Open, Vol 12, Iss 11 (2022)
Introduction Adoptive cell transfer of genetically engineered T cells is a promising treatment for malignancies; however, there are few ideal cancer antigens expressed on the cell surface, and the development of chimeric antigen receptor T cells (CAR
Externí odkaz:
https://doaj.org/article/bb9809a70ebe4968b8c6ed77e521b719
Autor:
Hiroshi Shiku, Naoyuki Katayama, Kazutoh Takesako, Junichi Mineno, Ikuei Nukaya, Daisuke Tomura, Hirofumi Yoshioka, Tomohide Kidokoro, Masashige Tanabe, Naoki Inoue, Taizo Shiraishi, Kohshi Ohishi, Hiroaki Naota, Satoshi Kokura, Takeshi Ishikawa, Shugo Ueda, Sahoko Sugino, Kanako Saito, Mikiya Ishihara, Naoko Imai, Yoshihiro Miyahara, Hiroaki Ikeda, Shinichi Kageyama
Adoptive transfer of MAGE-A4 T-cell receptor gene−transduced lymphocytes in patients with recurrent esophageal cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a05db4f3837a87f220f5fd30fb26204
https://doi.org/10.1158/1078-0432.22457964
https://doi.org/10.1158/1078-0432.22457964
Autor:
Hiroshi Shiku, Naoyuki Katayama, Kazutoh Takesako, Junichi Mineno, Ikuei Nukaya, Daisuke Tomura, Hirofumi Yoshioka, Tomohide Kidokoro, Masashige Tanabe, Naoki Inoue, Taizo Shiraishi, Kohshi Ohishi, Hiroaki Naota, Satoshi Kokura, Takeshi Ishikawa, Shugo Ueda, Sahoko Sugino, Kanako Saito, Mikiya Ishihara, Naoko Imai, Yoshihiro Miyahara, Hiroaki Ikeda, Shinichi Kageyama
Disease progression and overall survival of 10 patients who received transfer of TCR-transduced lymphocytes.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f31f40d6bea1982d6bef623527fd30a
https://doi.org/10.1158/1078-0432.22457943.v1
https://doi.org/10.1158/1078-0432.22457943.v1
Autor:
Hiroshi Shiku, Naoyuki Katayama, Kazutoh Takesako, Junichi Mineno, Ikuei Nukaya, Daisuke Tomura, Hirofumi Yoshioka, Tomohide Kidokoro, Masashige Tanabe, Naoki Inoue, Taizo Shiraishi, Kohshi Ohishi, Hiroaki Naota, Satoshi Kokura, Takeshi Ishikawa, Shugo Ueda, Sahoko Sugino, Kanako Saito, Mikiya Ishihara, Naoko Imai, Yoshihiro Miyahara, Hiroaki Ikeda, Shinichi Kageyama
Purpose: Preparative lymphodepletion, the temporal ablation of the immune system, has been reported to promote persistence of transferred cells along with increased rates of tumor regression in patients treated with adoptive T-cell therapy. However,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::435287d64f78540ed161bfddcd2e6aff
https://doi.org/10.1158/1078-0432.c.6523764.v1
https://doi.org/10.1158/1078-0432.c.6523764.v1
Autor:
Hiroshi Shiku, Naoyuki Katayama, Kazutoh Takesako, Junichi Mineno, Ikuei Nukaya, Daisuke Tomura, Hirofumi Yoshioka, Tomohide Kidokoro, Masashige Tanabe, Naoki Inoue, Taizo Shiraishi, Kohshi Ohishi, Hiroaki Naota, Satoshi Kokura, Takeshi Ishikawa, Shugo Ueda, Sahoko Sugino, Kanako Saito, Mikiya Ishihara, Naoko Imai, Yoshihiro Miyahara, Hiroaki Ikeda, Shinichi Kageyama
Peptides which have homologue sequences with MAGE-A4143-151 peptide.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::440d376ad6a083a3536ef12bbf844d64
https://doi.org/10.1158/1078-0432.22457937
https://doi.org/10.1158/1078-0432.22457937
Autor:
Yasuhiro Nagata, Shinichi Kageyama, Takeshi Ishikawa, Satoshi Kokura, Tetsuya Okayama, Tetsuya Abe, Masahiko Murakami, Koji Otsuka, Tomotake Ariyoshi, Takashi Kojima, Ken Taniguchi, Shinichiro Kobayashi, Hideaki Shimada, Satoshi Yajima, Takashi Suzuki, Satoshi Hirano, Takahiro Tsuchikawa, Toshiaki Shichinohe, Shugo Ueda, Kengo Kanetaka, Akira Yoneda, Hisashi Wada, Yuichiro Doki, Hiroki Yamaue, Masahiro Katsuda, Masaki Ohi, Hiromi Yasuda, Ken Kondo, Masato Kataoka, Yasuhiro Kodera, Masahiko Koike, Taizo Shiraishi, Yoshihiro Miyahara, Naoki Goshima, Eriko Fukuda, Kei Yamaguchi, Eiichi Sato, Hiroaki Ikeda, Tomomi Yamada, Masaharu Osako, Kaoru Hirai, Hiroshi Miyamoto, Takashi Watanabe, Hiroshi Shiku
Publikováno v:
Cancer Immunology, Immunotherapy. 71:2743-2755
The aim of this study was to determine the efficacy and the biomarkers of the CHP-NY-ESO-1 vaccine complexed with full-length NY-ESO-1 protein and a cholesteryl pullulan (CHP) in patients with esophageal squamous cell carcinoma (ESCC) after surgery.
Publikováno v:
Urology Case Reports, Vol 11, Iss C, Pp 19-21 (2017)
Inflammatory myofibroblastic tumor is a rare benign entity of unclear etiology. It can present with histological features that include a mixture of spindle cells, myofibroblasts and inflammatory cells. Positive immunohistochemical staining for ALK/p8
Externí odkaz:
https://doaj.org/article/69cc0e25cab9490d87903ab0bc2382c6
Autor:
Naozumi Harada, Katsunori Uchida, Takeshi Sasaki, Yoshiki Sugimura, Yasutaka Tono, Gill A Webster, Naoyuki Katayama, Shinichi Kageyama, Hiroshi Shiku, Toshiro Mizuno, Yoshihiro Miyahara, Hideki Kanda, Mikiya Ishihara, Eiichi Sato, Taizo Shiraishi, Yasuhide Hori, Norihito Soga, Hiroaki Ikeda, Daisuke Muraoka
Publikováno v:
Cancer Immunology, Immunotherapy
Cholesteryl pullulan (CHP) is a novel antigen delivery system. CHP and New York esophageal squamous cell carcinoma 1 (NY-ESO-1) antigen complexes (CHP-NY-ESO-1) present multiple epitope peptides to the MHC class I and II pathways. Adjuvants are essen
Publikováno v:
Journal of Cytology, Vol 31, Iss 2, Pp 93-95 (2014)
Acinar cell carcinomas (ACCs) of the pancreas are a rare tumor accounting for only about 2% of all pancreas tumors. We report herein on this case and discuss how to distinguish ACCs from neuroendocrine tumors (NETs) and solid pseudo-papillary tumor (
Externí odkaz:
https://doaj.org/article/74e5fc0e21714c8eb69f84025797225f